Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
AKORN INC (0000003116)
Standardized SEC financial data for AKORN INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000003116 · Pharmaceutical Preparations.
Gross margin
35.5%
Operating margin
-27.1%
Net margin
-57.9%
Revenue growth (YoY)
-17.5%
Return on equity
-171.5%
ROIC
-15.9%
Free cash flow
-$67.4M
Debt / equity
3.60×
Ratios for fiscal year 2018, standardized from SEC filings.